Sailaja Puttagunta
Chief Tech/Sci/R&D Officer at ITERUM THERAPEUTICS PLC
Net worth: 15 968 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ron Hunt | M | 59 | 15 years | |
| Michael Dunne | M | 64 | 14 years | |
| Corey N. Fishman | M | 59 | 9 years | |
| Russell Greig | M | 71 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Jonas Grossman | M | 50 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Beth Hecht | F | 60 | 5 years | |
| David George Kelly | M | 63 | 8 years | |
| Assaf Oron | M | 49 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 7 years |
| Jonathan Solomon | M | 47 | 5 years | |
| Alan Moses | M | 76 | 4 years | |
| Judith M. Matthews | F | 54 | 9 years | |
| Merav Bassan | M | 59 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 years |
| Louise Barrett | F | - | 7 years | |
| Myriam Golembo | M | 59 | 5 years | |
| Steven Aronin | M | - | 7 years | |
| Tom Loughman | M | - | 8 years | |
| Inbal Benjamini-Elran | F | - | 4 years | |
| Anat Primovich | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Giacobello | M | 54 | 7 years | |
| Brent Ahrens | M | 61 | 8 years | |
| Erez Chimovits | M | 60 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 4 years |
| David Adam Buchen | M | 59 | 1 years | |
| Ambrose Bailey | M | 60 | - | |
| Paul Edick | M | 67 | 4 years | |
| Dov Goldstein | M | 56 | 4 years | |
| Jirí Michal | M | 71 | 2 years | |
| Mohammed Malik | M | 56 | 4 years | |
| Robert Woodman | M | 46 | 1 years | |
| Andrew L. Turner | M | 77 | 2 years | |
| Yaron Breski | M | 46 | 1 years | |
| Marina Wolfson | F | 40 | 3 years | |
| Lisa Giles | F | 65 | 2 years | |
| Mark Chin | M | 42 | 6 years | |
| Lynne Sullivan | F | 58 | 5 years | |
| Peter John McDonnell | M | 66 | 5 years | |
| Allison Wey | F | - | 3 years | |
| Michael R. Gallagher | M | 77 | 2 years | |
| Paul Friedman | M | 81 | 1 years | |
| John A. King | M | 74 | 2 years | |
| Paul Sekhri | M | 66 | 2 years | |
| Hafrun Fridriksdottir | M | 62 | 14 years | |
| George F. Horner | M | 80 | 3 years | |
| Kevin O'Boyle | M | 68 | 2 years | |
| Nicole Vitullo | F | 66 | 5 years | |
| James Healy | M | 58 | 4 years | |
| Richard de Schutter | M | 83 | 2 years | |
| Gbola Amusa | M | 50 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 1 years |
| David Melnick | M | 72 | - | |
| Yao Lee | M | 54 | 4 years | |
| Nori Ebersole | F | 60 | 18 years | |
| Jeff Schaffnit | M | - | - | |
| John J. White | M | - | 1 years | |
| Ian A. Critchley | M | - | 3 years | |
| Inbar Gahali Sass | M | 51 | - | |
| Kathleen Reape | M | 58 | 1 years | |
| Kathryn DiMarco | F | 57 | 5 years | |
| Megan Schoeps | F | 40 | 2 years | |
| J. Carroll | M | 74 | - | |
| Sue-Jean Lin | F | 65 | 26 years | |
| Jonathan Garen | M | 58 | - | |
| Charles M. Mayr | M | 67 | 3 years | |
| John Shannon | M | 62 | 2 years | |
| Paul Navarre | M | - | - | |
| Timothy Lu | M | 43 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 4 years |
| Leonard Dove | M | 51 | 2 years | |
| Wendy Yarno | F | 68 | - | |
| Uri Ben-Or | M | 52 | 1 years | |
| Robert Hopfner | M | 51 | 1 years | |
| Richard Spivey | M | 74 | 5 years | |
| Aaron Cameron | M | 39 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 36 | 51.43% |
| Israel | 19 | 27.14% |
| United States | 18 | 25.71% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sailaja Puttagunta
- Personal Network
